Theriva Biologics, Inc. Earnings Per Share, Basic and Diluted
Theriva Biologics, Inc. (TOVX) reported Earnings Per Share, Basic and Diluted of -$0.02 per share for the 3-month period ending 2021-06-30, per its 10-Q filed 2021-08-05.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2021-08-05
- Theriva Biologics, Inc. earnings per share, basic and diluted for the quarter ending 2021-06-30 was -$0.02.
- Theriva Biologics, Inc. earnings per share, basic and diluted for the quarter ending 2021-03-31 was -$0.13.
- Theriva Biologics, Inc. earnings per share, basic and diluted for the quarter ending 2020-12-31 was -$0.15.
- Theriva Biologics, Inc. earnings per share, basic and diluted for the quarter ending 2020-09-30 was -$0.14.
- Theriva Biologics, Inc. earnings per share, basic and diluted for fiscal 2020 was -$0.66.
- Theriva Biologics, Inc. earnings per share, basic and diluted for fiscal 2019 was -$0.98.
- Theriva Biologics, Inc. earnings per share, basic and diluted for fiscal 2018 was -$4.06.
- Theriva Biologics, Inc. earnings per share, basic and diluted for fiscal 2017 was -$6.23.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 3 month as first filed | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 6 month as first filed | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 9 month as first filed | Earnings Per Share, Basic and Diluted 12 month | Earnings Per Share, Basic and Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2021-06-30 | -$0.02 10-Q · filed 2021-08-05 | -$0.13 10-Q · filed 2021-08-05 | -$0.22 derived: net income ÷ weighted average shares · filed 2022-08-11 | -$0.31 derived: net income ÷ weighted average shares · filed 2022-08-11 | ||||
| 2021-03-31 | -$0.13 10-Q · filed 2021-05-05 | -$0.26 derived: net income ÷ weighted average shares · filed 2022-05-16 | -$0.39 derived: net income ÷ weighted average shares · filed 2022-05-16 | -$0.55 derived: net income ÷ weighted average shares · filed 2022-05-16 | ||||
| 2020-12-31 | -$0.15 derived: net income ÷ weighted average shares · filed 2022-03-16 | -$0.29 derived: net income ÷ weighted average shares · filed 2022-03-16 | -$0.46 derived: net income ÷ weighted average shares · filed 2022-03-16 | -$0.66 10-K · filed 2021-03-04 | ||||
| 2020-09-30 | -$0.14 10-Q · filed 2020-11-10 | -$0.32 derived: net income ÷ weighted average shares · filed 2021-11-03 | -$0.52 10-Q · filed 2020-11-10 | -$0.70 derived: net income ÷ weighted average shares · filed 2021-11-03 | ||||
| 2020-06-30 | -$0.18 10-Q · filed 2021-08-05 | -$0.38 10-Q · filed 2021-08-05 | -$0.57 derived: net income ÷ weighted average shares · filed 2021-08-05 | -$0.88 derived: net income ÷ weighted average shares · filed 2021-08-05 | ||||
| 2020-03-31 | -$0.20 10-Q · filed 2021-05-05 | -$0.39 derived: net income ÷ weighted average shares · filed 2021-05-05 | -$0.70 derived: net income ÷ weighted average shares · filed 2021-05-05 | -$0.92 derived: net income ÷ weighted average shares · filed 2021-05-05 | ||||
| 2019-12-31 | -$0.19 derived: net income ÷ weighted average shares · filed 2021-03-04 | -$0.50 derived: net income ÷ weighted average shares · filed 2021-03-04 | -$0.73 derived: net income ÷ weighted average shares · filed 2021-03-04 | -$0.98 10-K · filed 2021-03-04 | ||||
| 2019-09-30 | -$0.31 10-Q · filed 2020-11-10 | -$0.54 derived: net income ÷ weighted average shares · filed 2020-11-10 | -$0.79 10-Q · filed 2020-11-10 | -$1.78 derived: net income ÷ weighted average shares · filed 2020-11-10 | ||||
| 2019-06-30 | -$0.23 10-Q · filed 2020-08-06 | -$0.48 10-Q · filed 2020-08-06 | -$1.49 derived: net income ÷ weighted average shares · filed 2020-08-06 | -$2.12 derived: net income ÷ weighted average shares · filed 2020-08-06 | ||||
| 2019-03-31 | -$0.25 10-Q · filed 2020-05-05 | -$1.29 derived: net income ÷ weighted average shares · filed 2020-05-05 | -$2.04 derived: net income ÷ weighted average shares · filed 2020-05-05 | -$2.92 derived: net income ÷ weighted average shares · filed 2020-05-05 | ||||
| 2018-12-31 | -$1.10 derived: net income ÷ weighted average shares · filed 2020-02-20 | -$2.13 derived: net income ÷ weighted average shares · filed 2020-02-20 | -$3.24 derived: net income ÷ weighted average shares · filed 2020-02-20 | -$4.06 10-K · filed 2020-02-20 | ||||
| 2018-09-30 | -$0.93 10-Q · filed 2019-11-04 | -$2.07 derived: net income ÷ weighted average shares · filed 2019-11-04 | -$2.73 10-Q · filed 2019-11-04 | -$2.01 derived: net income ÷ weighted average shares · filed 2019-11-04 | ||||
| 2018-06-30 | -$1.16 10-Q · filed 2019-08-08 | -$0.03 10-Q · filed 2018-08-08 | -$1.80 10-Q · filed 2019-08-08 | -$0.05 10-Q · filed 2018-08-08 | -$1.05 derived: net income ÷ weighted average shares · filed 2019-08-08 | -$5.90 derived: net income ÷ weighted average shares · filed 2019-08-08 | ||
| 2018-03-31 | -$0.65 10-Q · filed 2019-05-08 | -$0.02 10-Q · filed 2018-05-08 | $0.11 derived: net income ÷ weighted average shares · filed 2019-05-08 | -$4.74 derived: net income ÷ weighted average shares · filed 2019-05-08 | -$0.65 derived: net income ÷ weighted average shares · filed 2019-05-08 | |||
| 2017-12-31 | $0.76 derived: net income ÷ weighted average shares · filed 2019-02-27 | -$4.10 derived: net income ÷ weighted average shares · filed 2019-02-27 | -$0.44 derived: net income ÷ weighted average shares · filed 2019-02-27 | -$6.23 10-K · filed 2019-02-27 | -$0.18 10-K · filed 2018-02-22 | |||
| 2017-09-30 | -$4.90 10-Q · filed 2018-11-08 | -$0.14 10-Q · filed 2017-11-01 | -$0.35 derived: net income ÷ weighted average shares · filed 2018-11-08 | -$7.00 10-Q · filed 2018-11-08 | -$0.20 10-Q · filed 2017-11-01 | -$0.31 derived: net income ÷ weighted average shares · filed 2018-11-08 | ||
| 2017-06-30 | -$0.03 10-Q · filed 2018-08-08 | -$0.06 10-Q · filed 2018-08-08 | -$0.08 derived: net income ÷ weighted average shares · filed 2018-08-08 | -$0.16 derived: net income ÷ weighted average shares · filed 2018-08-08 | ||||
| 2017-03-31 | -$0.02 10-Q · filed 2018-05-08 | -$0.05 derived: net income ÷ weighted average shares · filed 2018-05-08 | -$0.13 derived: net income ÷ weighted average shares · filed 2018-05-08 | |||||
| 2016-12-31 | -$0.02 derived: net income ÷ weighted average shares · filed 2018-02-22 | -$0.11 derived: net income ÷ weighted average shares · filed 2018-02-22 | -$0.29 10-K · filed 2018-02-22 | |||||
| 2016-09-30 | -$0.09 10-Q · filed 2017-11-01 | -$0.27 10-Q · filed 2017-11-01 | ||||||
| 2016-06-30 | -$0.06 10-Q · filed 2017-08-03 | -$0.18 10-Q · filed 2017-08-03 | ||||||
| 2016-03-31 | -$0.12 10-Q · filed 2017-05-04 | |||||||
| 2015-12-31 | -$0.54 10-K · filed 2018-02-22 | |||||||
| 2015-06-30 | -$0.19 10-Q · filed 2015-08-10 | -$0.36 10-Q · filed 2015-08-10 | ||||||
| 2015-03-31 | -$0.17 10-Q · filed 2016-05-05 | |||||||
| 2014-12-31 | -$0.10 10-K · filed 2016-03-10 | -$0.32 10-K · filed 2017-03-02 | ||||||
| 2014-09-30 | -$0.08 10-K · filed 2016-03-10 | -$0.23 10-Q · filed 2014-11-14 | ||||||
| 2014-06-30 | -$0.08 10-K · filed 2016-03-10 | -$0.14 10-Q · filed 2015-08-10 | ||||||
| 2014-03-31 | -$0.07 10-K · filed 2016-03-10 | |||||||
| 2013-12-31 | -$0.08 10-K · filed 2015-03-16 | -$0.27 10-K · filed 2016-03-10 | ||||||
| 2013-09-30 | -$0.08 10-K · filed 2015-03-16 | -$0.18 10-Q · filed 2014-11-14 | ||||||
| 2013-06-30 | -$0.06 10-K · filed 2015-03-16 | -$0.11 10-Q · filed 2014-08-14 | ||||||
| 2013-03-31 | -$0.05 10-K · filed 2015-03-16 | |||||||
| 2012-12-31 | -$0.49 10-K · filed 2015-03-16 | |||||||
| 2012-09-30 | -$0.05 10-Q · filed 2013-11-14 | -$0.15 10-Q · filed 2013-11-14 | ||||||
| 2012-06-30 | -$0.05 10-Q · filed 2013-08-14 | -$0.09 10-Q · filed 2013-08-14 | ||||||
| 2012-03-31 | -$0.04 10-Q · filed 2013-05-15 | |||||||
| 2011-12-31 | -$0.29 10-K · filed 2013-04-16 | |||||||
| 2011-09-30 | -$0.04 10-Q · filed 2012-11-14 | -$0.18 10-Q · filed 2012-11-14 | ||||||
| 2011-06-30 | -$0.06 10-Q/A · filed 2012-09-11 | -$0.14 10-Q/A · filed 2012-09-11 | ||||||
| 2011-03-31 | -$0.09 10-Q · filed 2012-05-15 | |||||||
| 2010-12-31 | -$0.08 10-K/A · filed 2012-05-11 | |||||||
| 2010-09-30 | -$0.03 10-Q · filed 2011-11-14 | -$0.04 10-Q · filed 2011-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |